TScan Therapeutics cuts 75% of workforce, pauses Phase 3 ALLOHA-2 trial for TSC-101
TScan Therapeutics pauses Phase 3 ALLOHA-2 trial after 75% workforce cut, shifting focus to preclinical solid tumor development.
PMV Pharmaceuticals Structures Warrant Offering Around Rezatapopt NDA Acceptance
PMV Pharmaceuticals ties warrant pricing to rezatapopt NDA acceptance, betting on FDA review of 46% response rate data in...
Nanochon Enrolls First Patient in Chondrograft Knee Cartilage Study
Nanochon enrolls first patient in Chondrograft knee cartilage study, a 3D-printed implant designed for focal chondral defects with immediate...
Inventiva Completes NATiV3 Phase 3 Trial of Lanifibranor in MASH
Inventiva completes NATiV3 Phase 3 trial of lanifibranor in MASH with histological readout weeks away, challenging established competitors.
Ultragenyx’s apazunersen fails Phase 3 primary endpoint in Angelman syndrome
Ultragenyx's apazunersen fails Phase 3 primary endpoint in Angelman syndrome, missing both cognitive and multidomain responder measures.
Ivonescimab Meets Overall Survival Endpoint Against Pembrolizumab in Phase III Trial
Ivonescimab meets overall survival endpoint against pembrolizumab in Phase III HARMONi-2 trial, with statistically significant results expected to influence...
When the CRO and Sponsor Speak the Same Language, Oversight Stops Being a Negotiation
Ed Fowler, Parexel's former Vice President of Operational Excellence, on what shared CTMS infrastructure has changed — and what...
The EMA Just Opened a Door That Animal Testing Has Kept Closed for Decades
EMA's September 2026 NAM data pilot lets sponsors share organ-chip and computational data directly with regulators, reshaping preclinical drug...
Veeva Launches Falcon Safety AI for Adverse Event Processing Across E2B Systems
Veeva Falcon Safety will streamline adverse event processing across E2B-compliant safety systems, including Oracle Argus and ArisGlobal LifeSphere.
Medtronic acquires distribution rights to Cornerstone Robotics’ Sentire surgical system for $700M
Medtronic acquires distribution rights to Cornerstone Robotics' Sentire surgical system for $700M to expand robotic surgery access in non-U.S....